Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for quality of life in patients with heart failure
IRCT20241103063574N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sertraline in heart failure (HF) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Quality of life, Efficacy of sertraline and 4 more. Started Dec 2024; status: completed.
02
Drugs
sertraline
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20241103063574N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241103063574N1.